| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.82B | +1.5% |
| Cost of Revenue | $800.0M | +7.3% |
| Gross Profit | $1.02B | -2.6% |
| R&D Expense | $263.6M | +9.8% |
| SG&A Expense | $275.7M | +0.8% |
| Operating Income | $481.7M | -8.6% |
| Pre-tax Income | $505.8M | -3.6% |
| Income Tax | $78.5M | -10.1% |
| Net Income | $427.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $527.8M | +82.9% |
| Short-term Investments | $580.6M | +29.2% |
| Accounts Receivable | $179.9M | -1.6% |
| Inventory | $383.7M | -14.2% |
| Current Assets | $1.82B | +29.0% |
| Total Assets | $2.43B | +18.2% |
| Current Liabilities | $235.0M | -10.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $638.2M | +158.7% |
| Capital Expenditures | $57.6M | -2.1% |
| Investing Cash Flow | -$178.7M | -1328.7% |
| Financing Cash Flow | -$183.7M | -42.7% |
| Free Cash Flow | $580.6M | +209.1% |
| -2.4% |
| EPS (Basic) | $8.98 | -4.2% |
| EPS (Diluted) | $8.76 | -3.2% |
| Total Liabilities |
| $384.4M |
| -1.5% |
| Stockholders' Equity | $2.05B | +22.9% |